Physician profile
Stephen Kim
NPI 1215158829
$44,894.31
in general payments reported to CMS, 2019-2025
7 companies · $8,506 in 2025
The $8,506 reported for 2025 was more than what 92% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,282 · 2020: $1,330 · 2021: $1,569 · 2022: $4,294 · 2023: $22K · 2024: $750 · 2025: $8,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $27K · Food and Beverage: $2,810 · Travel and Lodging: $1,319.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $27,290.00 |
| Food and Beverage | $2,809.87 |
| Travel and Lodging | $1,318.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $43,847.29 | 2019-2025 | Exalt Model D, Spyglass, Overstitch Endoscopic Suturing System |
| Conmed Corporation | $322.25 | 2019-2025 | Conmed Biliary |
| Covidien Lp | $210.55 | 2019 | |
| Steris Corporation | $141.72 | 2021 | |
| Ipsen Biopharmaceuticals, INC | $139.57 | 2022 | |
| Olympus America INC. | $132.97 | 2024 | Endoclot Sis, Single Use Electrosurgical Knife Kd-655, Visiglide |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $99.96 | 2024 | Xifaxan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Kim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.